Literature DB >> 19301472

Prolonged transgene expression with lentiviral vectors in the aqueous humor outflow pathway of nonhuman primates.

Román A Barraza1, Carol A Rasmussen, Nils Loewen, J Douglas Cameron, B'Ann T Gabelt, Wu-Lin Teo, Paul L Kaufman, Eric M Poeschla.   

Abstract

We injected lentiviral vectors into the eyes of live nonhuman primates to assess potential for glaucoma gene therapy. Anterior chambers of five cynomolgus monkeys were injected with green fluorescent protein (GFP)-encoding feline immunodeficiency viral vectors. The monkeys were monitored for in vivo transgene expression and clinical parameters. Their eyes were harvested 2-15 months postinjection for tissue analyses. All seven eyes injected with 1.0-2.0 x 10(8) transducing units (TU) showed substantial GFP fluorescence in the trabecular meshwork (TM), which was observable even by goniophotographic monitoring for up to 15 months. Only the lowest dose (0.03 x 10(8) TU) failed to result in TM fluorescence detectable in vivo, and five of the eight vector-injected eyes continued to display substantial GFP expression when enucleated eyes were examined at 2, 7, or 15 months postinjection. Some transduced cells were also detected in the iris and ciliary body. Mild, transient postinjection inflammatory responses exceeding that induced by a control saline injection were observed, but vectors did not raise intraocular pressure and were well tolerated. The results demonstrate the first lentiviral vector transduction of the nonhuman primate aqueous humor outflow pathway and support application of the system to human glaucoma gene therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19301472      PMCID: PMC2855254          DOI: 10.1089/hum.2008.086

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  56 in total

1.  Stable gene transfer to the nervous system using a non-primate lentiviral vector.

Authors:  K Mitrophanous; S Yoon; J Rohll; D Patil; F Wilkes; V Kim; S Kingsman; A Kingsman; N Mazarakis
Journal:  Gene Ther       Date:  1999-11       Impact factor: 5.250

2.  Stromelysin gene transfer into cultured human trabecular cells and rat trabecular meshwork in vivo.

Authors:  C Kee; S Sohn; J M Hwang
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-11       Impact factor: 4.799

3.  Adult-onset primary open-angle glaucoma caused by mutations in optineurin.

Authors:  Tayebeh Rezaie; Anne Child; Roger Hitchings; Glen Brice; Lauri Miller; Miguel Coca-Prados; Elise Héon; Theodore Krupin; Robert Ritch; Donald Kreutzer; R Pitts Crick; Mansoor Sarfarazi
Journal:  Science       Date:  2002-02-08       Impact factor: 47.728

4.  Modulation of aqueous humor outflow facility by the Rho kinase-specific inhibitor Y-27632.

Authors:  P V Rao; P F Deng; J Kumar; D L Epstein
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-04       Impact factor: 4.799

Review 5.  Gene therapy for glaucoma: treating a multifaceted, chronic disease.

Authors:  Teresa Borrás; Curtis R Brandt; Robert Nickells; Robert Ritch
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-08       Impact factor: 4.799

Review 6.  From PGF(2alpha)-isopropyl ester to latanoprost: a review of the development of xalatan: the Proctor Lecture.

Authors:  J W Stjernschantz
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-05       Impact factor: 4.799

7.  Genetic modification of human trabecular meshwork with lentiviral vectors.

Authors:  N Loewen; M P Fautsch; M Peretz; C K Bahler; J D Cameron; D H Johnson; E M Poeschla
Journal:  Hum Gene Ther       Date:  2001-11-20       Impact factor: 5.695

8.  Non-invasive observation of repeated adenoviral GFP gene delivery to the anterior segment of the monkey eye in vivo.

Authors:  T Borrás; B T Gabelt; G K Klintworth; J C Peterson; P L Kaufman
Journal:  J Gene Med       Date:  2001 Sep-Oct       Impact factor: 4.565

Review 9.  Human gene therapy vectors derived from feline lentiviruses.

Authors:  Román A Barraza; Eric M Poeschla
Journal:  Vet Immunol Immunopathol       Date:  2008-01-19       Impact factor: 2.046

10.  The antiviral efficacy of the murine alpha-1 interferon transgene against ocular herpes simplex virus type 1 requires the presence of CD4(+), alpha/beta T-cell receptor-positive T lymphocytes with the capacity to produce gamma interferon.

Authors:  Daniel J J Carr; Sansanee Noisakran
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

View more
  30 in total

Review 1.  Deconstructing aqueous humor outflow - The last 50 years.

Authors:  Paul L Kaufman
Journal:  Exp Eye Res       Date:  2020-06-23       Impact factor: 3.467

Review 2.  Gene therapy for ocular diseases.

Authors:  Melissa M Liu; Jingsheng Tuo; Chi-Chao Chan
Journal:  Br J Ophthalmol       Date:  2010-08-23       Impact factor: 4.638

3.  Advances in glaucoma treatment and management: outflow drugs.

Authors:  Paul L Kaufman; Carol A Rasmussen
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-05-04       Impact factor: 4.799

4.  Self-complementary AAV virus (scAAV) safe and long-term gene transfer in the trabecular meshwork of living rats and monkeys.

Authors:  LaKisha K Buie; Carol A Rasmussen; Eric C Porterfield; Vinod S Ramgolam; Vivian W Choi; Silva Markovic-Plese; Richard J Samulski; Paul L Kaufman; Teresa Borrás
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-08-13       Impact factor: 4.799

Review 5.  Exciting directions in glaucoma.

Authors:  Carol A Rasmussen; Paul L Kaufman
Journal:  Can J Ophthalmol       Date:  2014-12       Impact factor: 1.882

6.  Knockdown of NBCe1 in vivo compromises the corneal endothelial pump.

Authors:  Cailing Liu; Qiang Cheng; Tracy Nguyen; Joseph A Bonanno
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-05-05       Impact factor: 4.799

7.  Comparisons of actin filament disruptors and Rho kinase inhibitors as potential antiglaucoma medications.

Authors:  Baohe Tian; Paul L Kaufman
Journal:  Expert Rev Ophthalmol       Date:  2012-04

Review 8.  Prospects for lentiviral vector mediated prostaglandin F synthase gene delivery in monkey eyes in vivo.

Authors:  Eun Suk Lee; Carol A Rasmussen; Mark S Filla; Sarah R Slauson; Aaron W Kolb; Donna M Peters; Paul L Kaufman; B'Ann T Gabelt; Curtis R Brandt
Journal:  Curr Eye Res       Date:  2014-02-21       Impact factor: 2.424

9.  Prostaglandin pathway gene therapy for sustained reduction of intraocular pressure.

Authors:  Román A Barraza; Jay W McLaren; Eric M Poeschla
Journal:  Mol Ther       Date:  2009-12-01       Impact factor: 11.454

10.  COCH transgene expression in cultured human trabecular meshwork cells and its effect on outflow facility in monkey organ cultured anterior segments.

Authors:  Eun Suk Lee; B'ann T Gabelt; Jennifer A Faralli; Donna M Peters; Curtis R Brandt; Paul L Kaufman; Sanjoy K Bhattacharya
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-11-20       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.